A biological perspective of breast cancer: Contributions of the national surgical adjuvant breast and bowel project clinical trials

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Ca

• Publication date

  1991-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3322/CANJCLIN.41.2.97PMID 1847652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Lumpectomy for breast cancer: an update of the NSABP experience. National Surgical Adjuvant Breast and Bowel Project.

  1992cited by this paper
• Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowe

  1990cited by this paper
• Postoperative chemotherapy and tamoxifen compared with tamoxifen alone in the treatment of positive-node breast cancer patients aged 50 years and older with tumors responsive to tamoxifen: results from the National Surgical Adjuvant Breast and Bowel Project B-16.

  1990cited by this paper
• Primary chemotherapy to avoid mastectomy in tumors with diameters of three centimeters or more.

  1990cited by this paper
• A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors.

  1989cited by this paper
• Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

  1989cited by this paper
• A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors.

  1989cited by this paper
• Presence of a growth-stimulating factor in serum following primary tumor removal in mice.

  1989cited by this paper
• Systemic therapy in patients with node-negative breast cancer. A commentary based on two National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trials.

  1989cited by this paper
• Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

  1988cited by this paper
• Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.

  1986cited by this paper
• Anatagonism of the cytocidal activity and uptake of melphalan by tamoxifen in human breast cancer cells in vitro

  1985cited by this paper
• Tamoxifen-citrate counteracts the antitumor effects of cytotoxic drugs in vitro.

  1985cited by this paper
• Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer.

  1985cited by this paper
• Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation.

  1985cited by this paper
• Dose-response effect of adjuvant chemotherapy in breast cancer.

  1981cited by this paper
• The contribution of recent nsabp clinical trials of primary breast cancer therapy to an understanding of tumor biology—an overview of findings

  1980cited by this paper
• Laboratory and clinical research in breast cancer--a personal adventure: the David A. Karnofsky memorial lecture.

  1980cited by this paper
• Breast-Cancer Management

  1979cited by this paper
• A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate.

  1979cited by this paper
• L‐phenylalanine mustard (L‐PAM) in the management of primary breast cancer: An update of earlier findings and a comparison with those utilizing L‐PAM plus 5‐fluorouracil (5‐FU)

  1977cited by this paper
• Comparison of radical mastectomy with alternative treatments for primary breast cancer: A first report of results from a prospective randomized clinical trial

  1977cited by this paper
• 1-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.

  1975cited by this paper
• Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy.

  1975cited by this paper
• Kinetics of mammary tumor cell growth and implications for therapy

  1971cited by this paper
• The surgical dilemma in the primary therapy of invasive breast cancer: a critical appraisal.

  1970cited by this paper
• Surgical Adjuvant Chemotherapy in Cancer of the Breast: Results of a Decade of Cooperative Investigation

  1968cited by this paper
• The growth fraction, a new concept applied to tumors. Abstr.

  1960cited by this paper

• Breast Cancer Epidemiology and Contemporary Breast Cancer Care: A Review of the Literature and Clinical Applications.

  2022cites this paper
• Early Breast Cancers

  2015cites this paper
• Adjuvant/Neoadjuvant Systemic Therapies in Breast Cancer

  2015cites this paper
• Adjuvant systemic therapies in breast cancer.

  2013cites this paper
• Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

  2002cites this paper
• TWENTY-FIVE-YEAR FOLLOW-UP OF A RANDOMIZED TRIAL COMPARING RADICAL MASTECTOMY , TOTAL MASTECTOMY , AND TOTAL MASTECTOMY

  2002cites this paper
• The role of prospective randomized clinical trials in pediatric surgery: state of the art?

  2001cites this paper
• Comparative evaluation of the efficiency of various Ukrain doses in the combined treatment of breast cancer. Report 1. Clinical aspects of Ukrain application.

  2000cites this paper
• Magnetic resonance imaging of breast cancer: Clinical indications and breast MRI reporting system

  2000cites this paper
• Comparison of the efficacy of different doses of Ukrain in the combined treatment of breast cancer.

  2000cites this paper
• The immunology and immunotherapy of breast cancer: an update.

  1999cites this paper
• Highlights from recent National Surgical Adjuvant Breast and Bowel Project studies in the treatment and prevention of breast cancer

  1999cites this paper
• Risk of recurrence after ductal carcinoma in situ of the breast.

  1998cites this paper
• Predictors of breast-conserving surgery in Connecticut, 1990–1992

  1997cites this paper
• Management of ductal carcinoma in situ of the breast.

  1995cites this paper
• The Immunology of Breast Cancer

  1995cites this paper
• Breast conservation therapy for invasive breast cancer: a review of prior trials and the Mayo Clinic experience.

  1994cites this paper
• Application of the adenosine triphosphate‐cell viability assay in human breast cancer chemosensitivity testing: A report on the first results

  1993cites this paper
• Tamoxifen and breast cancer—from palliation to prevention

  1993cites this paper
• Treatment of malignancies, past and present.

  1993cites this paper
• Duct carcinoma in situ: 227 cases without microinvasion.

  1992cites this paper
• Innovative therapies in hematology and oncology.

  1992cites this paper
• DNA flow cytometric analysis and prognosis of axillary lymph node‐negative breast carcinoma

  1992cites this paper